Vitaly A. Fishbein MD, FACG

1. Fishbein VA, Norton J, Benya RV, Pisegna JR, Metz DC,Jensen RT. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: A prospective study of the best approach. Ann Int Med . 1993;119. 3: 199-206.

2. Fishbein VA, Rosen A, Lack EE, Montgomery EA, Fleischer D. Diffuse hemorrhagic gastroenteropathy. Report of new entity. Gastroenterology 1994; 106: 500-505.

3. V.A. Fishbein, D.H. Coy, S. J. Hogart, N.Z. Jiang, R.T. Jensen. A Chimeric VIP-PACAP Analogue but not VIP Pseudopeptides function as VIP Receptor antagonists. Peptides. 15; 95-100: 1994

4. Metz DC, Pisegna JR, Fishbein VA, Benya RV, Jensen RT. The control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J Surg 1993;17:468-80

5. Benya RV, Metz DC, Norton JA, Fishbein VA, Pisegna JR, Jensen RT. The utility of fine needle aspiration cytology (FNAC) inthe evaluation of gastric and duodenal nodules in patients with Zollinger-Ellison syndrome.(ZES). Am J Gastroenterology. 2;1993

6. Metz DC, Pisegna JR, Fishbein VA, Benya RV, Feigenbaum KM, Koviack PD, Jensen RT. Currently used doses of omeprazole in the management of gastric acid hypersecretion in Zollinger-Ellison syndrome are too high. Gastroenterology , 11: 1992

7. Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbein VA, Benya RV, Shawker TH, Doppman JL, Jensen RT: A prospective study of intraoperative methods to find and resect duodenal gastrinomas. Ann of Surgery 218:138-144; 1993.

8. Metz DC, Benya RV, Fishbein VA, Pisegna JR, Norton JA, Jensen RT: Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection. Gastroenterology 1992 (submitted)

9. Pisegna JR, Slimak GG, Metz DC, Fishbein VA, Jensen RT et al.: Human recombinant interferon in patients with metastatic gastrinoma: A prospective study. Gastroenterology 1993;105:1179-1183

10. Knihgt M, Takahashi K, Burke TR, Pineda JD, Fishbein VA, Jensen RT and Moody TW. : Synthesis and biological activity of cholecystokinin antagonists. in Growth Factors, Peptides and Receptors. Edited by Terry W. Moody. Plenum Publishing Co., New York. N.Y. 1994

11. Metz DC, Pisegna JR, Fishbein VA, Benya RV, Jensen RT: Ranitidine withdrawal after succesful surgical resection in patients with Zollinger-Ellison syndrome. Gastroenterology 1994

12. Benya RV, Metz DC, Venzon DJ, Fishbein VA, Strader DB, Orbuch M, Jensen RT : Gastrinoma can be the initial presentation for patients with Multiple Endocrine Neoplasia Type I (MEN-1). American Journal of Medicine 97: 5; 436-444

13. Strader DB, Orbuch M, Fishbein VA, Benya RV, Benjamin SB, Lubensky I, Jensen RT, Metz DC: Esophageal Function and Occurence of Barrett’s Esophagus in Zollinger-Ellison Syndrome. Digestion 1995: 56:347-356.

14. H.C. Weber, D.J. Venzon, Fishbein VA, Strader DB, Orbuch M, F. Gibril, Jensen RT: Determinants of metastatic rate and survival in patients with Zollinger-Ellison Syndrome (ZES): Results of prospective long-term study. Gastroenterology 1995;108:1637-1649

15. Orbuch M., Doppman Jl, Strader DB, Fishbein VA, Benya RV, Metz DC, Jensen RT.: Imaging for paancreatic endocrine Tumor Localization: Recent advances in Endocrine Tumors of the Pancreatis. Ed. Mignon M, Jensen RT. Front Gastrointstinal Res. Basel, Karger, 1995, vol 23, p268-281.

16. Strader DB, Doppman Jl, Orbuch M., Fishbein VA, Benya RV, Jensen RT.: Functional localization of pancreatic endocrine tumors. In: Mignon M, Jensen RT, eds. Endocrine Tumors of The Pancreas: Recent advances in Research and Management. New York: Karger;1995: 282-97